63968 Federal Register / Vol. 88, No. 179 / Monday, September 18, 2023 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Rational Systematic 

Characterization and Selection of Adjuvants 

for HIV Vaccine Candidates (R–CASA). 

Date: October 10, 2023. 

Time: 1:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Rockville, MD 

20892 (Virtual Meeting). 

Contact Person: Stephen Anthony Gallo, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, National Institute of Allergy 

and Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, MSC–9823, 

Rockville, MD 20852, (240) 669–2858, 

steve.gallo@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 12, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20105 Filed 9–15–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; ABCD Study® Data 

Use Certification (National Institute on 

Drug Abuse) 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30 days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact: Dr. Elizabeth A. 

Hoffman, Senior Scientific Program 

Manager, Division of Extramural 

Research, National Institute on Drug 

Abuse, C/O NIH Mail Center/Dock 11, 

3WFN Room 09C75 MSC 6021, 16071 

Industrial Drive, Gaithersburg, MD 

20877 (20892 for USPS), or call non-tollfree number (301) 594–2265 or Email 

your request, including your address to: 

elizabeth.hoffman@nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on April 26, 2023, page 25411 

(88 FR 25411) and allowed 60 days for 

public comment. No public comments 

were received. The purpose of this 

notice is to allow an additional 30 days 

for public comment. The National 

Institute on Drug Abuse (NIDA), 

National Institutes of Health, may not 

conduct or sponsor, and the respondent 

is not required to respond to, an 

information collection that has been 

extended, revised, or implemented on or 

after October 1, 1995, unless it displays 

a currently valid OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection Title: ABCD 

Study® Data Use Certification, 0925– 

NEW, exp., date XX/XX/XXXX, 

National Institute on Drug Abuse 

(NIDA), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: The purpose of this proposal 

is to inform data requestors about terms 

and conditions for using data generated 

by the Adolescent Brain Cognitive 

Development(SM) (ABCD) Study and to 

obtain signed agreements from 

requestors and their institutional 

officials attesting to their commitment 

to abide by the data use terms and 

conditions. These include using data for 

research purposes; adhering to human 

subjects research requirements; not 

distributing the data to non-authorized 

users; minimizing risk of participant 

identifiability; using data ethically and 

responsibly; and keeping the data 

secure. Users must include a brief 

description of their research project and 

submit their signed data use agreements 

to the data repository to gain access to 

the ABCD Study® data. Users who plan 

to conduct research studies specifically 

on American Indian/Alaska Native (AI/ 

AN) populations must submit an 

additional signed data use certification. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

2,000. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average time 

per response 

(in hours) 

Total annual 

burden hour 

Individuals (standard DUC form) ..................................................................... 1,800 1 1 1,800 

Individuals (additional AI/AN DUC form when applicable) .............................. 200 1 1 200 

Total .......................................................................................................... ........................ 2,000 ........................ 2,000 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 179 / Monday, September 18, 2023 / Notices 63969 

Lanette A. Palmquist, 

Project Clearance Liaison, National Institute 

on Drug Abuse, National Institutes of Health. 

[FR Doc. 2023–20075 Filed 9–15–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Minority Health 

and Health Disparities; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; NIMHD Mentored 

Career and Research Development Awards 

(Ks). 

Date: October 26–27, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIMHD, DEM II, Suite 800, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Deborah Ismond, Ph.D., 

Scientific Review Officer, Office of 

Extramural Research Administration, 

National Institute on Minority Health and 

Health Disparities, National Institutes of 

Health, 6707 Democracy Blvd., Suite 800, 

Bethesda, MD 20892, (301) 594–2704, 

ismonddr@mail.nih.gov. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; NIMHD Centers of 

Excellence in Investigator Development and 

Community Engagement (P50—Clinical Trial 

Optional). 

Date: November 1–2, 2023. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIMHD, DEM II, Suite 800, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Maryline Laude-Sharp, 

Ph.D., Scientific Review Officer, Office of 

Extramural Research Administration, 

National Institute on Minority Health and 

Health Disparities, National Institutes of 

Health, 6707 Democracy Boulevard, Suite 

800, Bethesda, MD 20892, 301–451–9536, 

mlaudesharp@mail.nih.gov. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; Community Level 

Interventions to Improve Minority Health 

and Reduce Health Disparities. 

Date: November 9, 2023. 

Time: 11:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIMHD, DEM II, Suite 800, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Ivan K. Navarro, Ph.D., 

Scientific Review Officer, Office of 

Extramural Research Administration 

National Institute on Minority Health and 

Health Disparities, National Institutes of 

Health, 6707 Democracy Blvd., Suite 800, 

Bethesda, MD 20892, 301–827–2061, 

ivan.navarro@nih.gov. 

Name of Committee: National Institute on 

Minority Health and Health Disparities 

Special Emphasis Panel; NIMHD Support for 

Conferences and Scientific Meetings (R13). 

Date: November 14, 2023. 

Time: 2:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

NIMHD, DEM II, Suite 800, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Xinli Nan, M.D., Ph.D., 

Scientific Review Officer, Office of 

Extramural Research Activities National 

Institute on Minority Health and Health 

Disparities, National Institutes of Health, 

6707 Democracy Boulevard, Suite 800, 

Bethesda, MD 20892, (301) 594–7784, 

Xinli.Nan@nih.gov. 

Dated: September 12, 2023. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20058 Filed 9–15–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Nursing Research; 

Notice of Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Nursing Research Special Emphasis Panel; 

Conflicting Application Review of NRRC 

Meeting. 

Date: October 10, 2023. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Nursing 

Research, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joshua Wolff, Ph.D., 

Scientific Review Officer/Social & Behavioral 

Scientist, Scientific Review Branch, National 

Institute of Nursing Research, 6701 

Democracy Boulevard, Bethesda, MD 20892, 

301–793–5758, Joshua.wolff@nih.gov. 

Name of Committee: National Institute of 

Nursing Research Special Emphasis Panel; 

NINR T32 Training Grant Applications 

Review Meeting. 

Date: October 26, 2023. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Nursing 

Research, 6701 Democracy Boulevard, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Nisan Bhattacharyya, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute of Nursing 

Research, 6701 Democracy Boulevard, Room 

720, Bethesda, MD 20892, 301–435–6979, 

nisan.bhattacharyya@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.361, Nursing Research, 

National Institutes of Health, HHS) 

Dated: September 12, 2023. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2023–20061 Filed 9–15–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 


lotter on DSK11XQN23PROD with NOTICES1